Top Markets
#1 Trillions Trillions +4,371.22%
#2 Ozapay Ozapay +37.63%
#3 UnifAI Network UnifAI Network +26.77%
#4 Aria.AI Aria.AI +21.95%
#5 Zano Zano +17.34%
#6 Osaka Protocol Osaka Protocol +14.21%
#7 StakeStone StakeStone +13.94%
#8 Vestra DAO Vestra DAO +11.91%
#9 River Pts River Pts +10.84%
#10 pippin pippin +10.64%
Coin of the day
Trillions Trillions
Impostazioni
Lingua
ITALIANO
Valuta
USD
Tema
Acticor Biotech SAS Acticor Biotech SAS

Acticor Biotech SAS

ALACT
Classifica tra le azioni #99999
Acticor Biotech SAS operates as a clinical stage biotechnology company that... Acticor Biotech SAS operates as a clinical stage biotechnology company that develops drugs for the treatment of acute phase of thrombotic diseases. The company develops glenzocimab, a humanized monoclonal antibody fragment that targets a specific platelet glycoprotein. It is also involved in two clinical programs in Phase II/III registration for the treatment of ischemic stroke; and two other Phase II trials addressing major cardiovascular emergencies with clinical results expected in ischemic stroke and Covid-19 respiratory distress syndrome. The company was incorporated in 2013 and is headquartered in Paris, France.
Prezzo delle azioni
$0.28545656
Capitalizzazione di mercato
$4.50M
Variazione (1 giorno)
5.97%
Variazione (1 anno)
0.00%
Paese
FR
Scambia Acticor Biotech SAS (ALACT)

Categoria

Healthcare
Rapporto P/S per Acticor Biotech SAS (ALACT)
Rapporto P/S al March 2026 TTM: 0.00
Secondo gli ultimi rapporti finanziari e il prezzo delle azioni di Acticor Biotech SAS, il rapporto P/S attuale (TTM) è 0.00. Alla fine del 2022, era pari a 0.00.
Storico del rapporto P/S per Acticor Biotech SAS da 2010 a 2026
Rapporto P/S alla fine di ogni anno
Anno Rapporto P/S Cambia
2026 (TTM) 0.00 0.00%
2023 0.00 0.00%
2022 0.00 0.00%
2021 0.00 0.00%
2020 0.00 0.00%
2019 0.00 -100.00%
2018 432.73 16,252.85%
2017 2.65 56.77%
2016 1.69 23.03%
2015 1.37 16.08%
2014 1.18 -11.28%
2013 1.33 -13.75%
2012 1.54 -29.62%
2011 2.19 -58.15%
2010 5.24 0.00%
Rapporto P/S per aziende simili o concorrenti
Azienda Rapporto P/S Differenza del rapporto P/S Il paese
Novo Nordisk A/S Novo Nordisk A/S
Novo Nordisk A/S
NVO.US
3.55 -
DK
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
9.90 -
US
Regeneron Pharmaceuticals, Inc. Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc.
REGN.US
5.40 -
US
UCB SA UCB SA
UCB SA
UCB.BR
6.14 -
BE
CSL Limited CSL Limited
CSL Limited
CSL.AX
3.04 -
AU